Cargando…

Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease

We describe a case of human tularemia caused by Francisella tularensis subsp. holarctica in a stem cell transplant recipient with chronic graft-versus-host disease who was receiving levofloxacin prophylaxis. The infection was characterized by pneumonia with septic complications. The patient was succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Weile, Jan, Seibold, Erik, Knabbe, Cornelius, Kaufmann, Martin, Splettstoesser, Wolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647492/
https://www.ncbi.nlm.nih.gov/pubmed/23647853
http://dx.doi.org/10.3201/eid1905.120377
_version_ 1782268739159326720
author Weile, Jan
Seibold, Erik
Knabbe, Cornelius
Kaufmann, Martin
Splettstoesser, Wolf
author_facet Weile, Jan
Seibold, Erik
Knabbe, Cornelius
Kaufmann, Martin
Splettstoesser, Wolf
author_sort Weile, Jan
collection PubMed
description We describe a case of human tularemia caused by Francisella tularensis subsp. holarctica in a stem cell transplant recipient with chronic graft-versus-host disease who was receiving levofloxacin prophylaxis. The infection was characterized by pneumonia with septic complications. The patient was successfully treated with doxycycline.
format Online
Article
Text
id pubmed-3647492
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-36474922013-05-14 Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease Weile, Jan Seibold, Erik Knabbe, Cornelius Kaufmann, Martin Splettstoesser, Wolf Emerg Infect Dis Dispatch We describe a case of human tularemia caused by Francisella tularensis subsp. holarctica in a stem cell transplant recipient with chronic graft-versus-host disease who was receiving levofloxacin prophylaxis. The infection was characterized by pneumonia with septic complications. The patient was successfully treated with doxycycline. Centers for Disease Control and Prevention 2013-05 /pmc/articles/PMC3647492/ /pubmed/23647853 http://dx.doi.org/10.3201/eid1905.120377 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Weile, Jan
Seibold, Erik
Knabbe, Cornelius
Kaufmann, Martin
Splettstoesser, Wolf
Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
title Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
title_full Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
title_fullStr Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
title_full_unstemmed Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
title_short Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
title_sort treatment of tularemia in patient with chronic graft-versus-host disease
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647492/
https://www.ncbi.nlm.nih.gov/pubmed/23647853
http://dx.doi.org/10.3201/eid1905.120377
work_keys_str_mv AT weilejan treatmentoftularemiainpatientwithchronicgraftversushostdisease
AT seibolderik treatmentoftularemiainpatientwithchronicgraftversushostdisease
AT knabbecornelius treatmentoftularemiainpatientwithchronicgraftversushostdisease
AT kaufmannmartin treatmentoftularemiainpatientwithchronicgraftversushostdisease
AT splettstoesserwolf treatmentoftularemiainpatientwithchronicgraftversushostdisease